Pataday eye drops

GPTKB entity

Statements (47)
Predicate Object
gptkbp:instance_of gptkb:Ophthalmology
gptkbp:approves gptkb:2000
gptkbp:brand gptkb:Pataday
gptkbp:category Category C
gptkbp:clinical_trial Phase III
well tolerated
effective in reducing symptoms
gptkbp:clinical_use relief of burning eyes
relief of itchy eyes
relief of redness
relief of watery eyes
gptkbp:community_service approved for children 2 years and older
gptkbp:contraindication hypersensitivity to olopatadine
gptkbp:dosage_form gptkb:liquid
gptkbp:duration up to 24 hours
gptkbp:formulation gptkb:cream
https://www.w3.org/2000/01/rdf-schema#label Pataday eye drops
gptkbp:indication seasonal allergic conjunctivitis
perennial allergic conjunctivitis
gptkbp:ingredients gptkb:olopatadine
gptkbp:label keep out of reach of children
shake well before use
for external use only
discard after 28 days of opening
do not touch tip to any surface
gptkbp:manufacturer gptkb:Alcon
gptkbp:mechanism_of_action H1 receptor antagonist
gptkbp:packaging gptkb:bottle
gptkbp:previous_name olopatadine hydrochloride
gptkbp:requires over-the-counter
gptkbp:route_of_administration ocular
gptkbp:side_effect headache
dry eyes
stinging
blurred vision
eye discomfort
eye irritation
burning sensation
red eyes
taste disturbance
gptkbp:storage room temperature
gptkbp:strength 0.2%
0.1%
0.7%
gptkbp:used_for allergic conjunctivitis
gptkbp:bfsParent gptkb:Bausch_+_Lomb
gptkbp:bfsLayer 7